CapsoVision (NASDAQ:CV) Trading 12.9% Higher – Here’s What Happened

CapsoVision, Inc. (NASDAQ:CV) shares were up 12.9% during mid-day trading on Wednesday . The stock traded as high as $14.69 and last traded at $14.56. Approximately 68,205 shares traded hands during trading, a decline of 58% from the average daily volume of 163,778 shares. The stock had previously closed at $12.90.

Wall Street Analysts Forecast Growth

Several brokerages recently weighed in on CV. Roth Capital set a $7.00 price target on shares of CapsoVision in a report on Tuesday, November 4th. Weiss Ratings reiterated a “sell (e)” rating on shares of CapsoVision in a research report on Monday. Benchmark reiterated a “speculative buy” rating on shares of CapsoVision in a research report on Friday, November 14th. Finally, Zacks Research upgraded shares of CapsoVision to a “hold” rating in a research report on Wednesday, November 5th. One research analyst has rated the stock with a Strong Buy rating, one has given a Buy rating, one has issued a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat, CapsoVision presently has a consensus rating of “Moderate Buy” and an average price target of $6.00.

CapsoVision Stock Up 4.4%

The company has a fifty day moving average price of $6.82.

CapsoVision (NASDAQ:CV) last issued its quarterly earnings results on Thursday, November 13th. The company reported ($0.17) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.14) by ($0.03). The company had revenue of $3.54 million during the quarter.

Hedge Funds Weigh In On CapsoVision

A hedge fund recently bought a new stake in CapsoVision stock. New York State Common Retirement Fund purchased a new position in shares of CapsoVision, Inc. (NASDAQ:CV) in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor purchased 7,114 shares of the company’s stock, valued at approximately $34,000.

CapsoVision Company Profile

CapsoVision, Inc (NASDAQ: CV) is a medical device company specializing in advanced capsule endoscopy systems for gastrointestinal diagnostics. The company’s flagship product, the CapsoCam® Plus System, features a swallowable, tether-free capsule equipped with four side-viewing cameras that capture high-resolution, 360-degree images of the small intestine. By storing images internally rather than transmitting data wirelessly, CapsoCam Plus enables patients to maintain normal daily activities during the procedure and reduces the risk of signal loss or image drop-out.

In addition to its capsule hardware, CapsoVision offers CapsoCloud®, a secure, cloud-based platform that streamlines image retrieval, storage and reporting.